Connected Health in the Developing World
Monday, March 24, 2008
| Paul Heinzelmann
About the author - Paul Heinzelmann, MD, MPH is a clinical instructor at Harvard Medical School and Operation Village Health Project Leader.
The world’s population is growing rapidly, people are living longer, and non-communicable diseases such as cardiovascular disease and diabetes are on the rise in even the poorest of countries. In addition, millions continue to die from HIV, tuberculosis, and malaria.
Information and communication technologies (ICTs) are powerful catalysts to the process of globalization and will likely transform clinical care and public health in all corners of the globe. In addition to facilitating medical education, administration and research, appropriate use of these technologies may:
- Enable greater access to health care
- Enhance quality of services delivered
- Improve effectiveness of public health and primary care interventions
Though the “digital divide” remains relatively wide, it is shrinking fast. Consider that the Global System for Mobile communications (GSM) now has over two billion mobile phone subscribers, and some predict that by 2009 will reach half of the world’s population. Still others predict that WiMax and other broadband networks will diffuse rapidly into emerging markets of the developing world over the next 10 years. International agencies such as the United Nations and the World Health Organization have also begun to explore for ICTs in the public health sectors of low and middle-income countries. In addition, there are many examples of small-scale projects scattered throughout the developing world.
Operation Village Health is one such initiative of the Center for Connected Health. This program allows providers in remote Cambodia to consult with Partners specialists in the care and management of their patients. To date, over 1000 telemedicine consultations have been completed from two sites in rural Cambodia over the past seven years. Surprisingly, many of these cases involved the management of chronic disease such as diabetes and hypertension, which have gone largely un-noticed in these regions.
Though it's fairly easy to understand how connected health technologies can positively transform care delivery in the US marketplace, many questions remain about the potential value to those living in remote and resource-constrained settings within the developing world.
I propose two questions:
How do you envision connected health technologies making an impact on the global burden of disease?
What do you perceive to be the biggest challenges to this vision?
Paul Heinzelmann, MD, MPH